Your Lungs Are Struggling, Your Genes May Be Why.

Your airways need to relax and dilate when you inhale. That relaxation happens via beta-2 adrenergic receptors (ADRB2) sitting on the smooth muscle cells lining your bronchi. When those receptors work properly, they respond to your nervous system’s “open now” signals and to rescue inhalers like albuterol. It’s a critical safety mechanism.

The Arg16Gly variant in ADRB2 (carried by roughly 40% of the population) changes how sensitive those receptors are. People with the Gly allele tend to have reduced bronchodilator response, meaning their airways don’t open as easily when they inhale a beta-agonist medication. Their receptors are less responsive to the chemical signal. Over time, their inhalers become less effective.

You experience this as breathlessness that doesn’t improve fully with your rescue inhaler. You use it, you get some relief, but not the relief you should. You might think your asthma or COPD is worsening, when actually your genetics are predisposing you to a weaker drug response. In high-pollution or high-allergen days, your lungs feel locked in a way your friends’ lungs don’t.

Cigarette smoke, air pollution, and industrial exposure create reactive oxygen species (free radicals) inside your lungs. Your body’s main defense is glutathione S-transferase (GST), a family of enzymes that bind those free radicals and neutralize them. GSTM1 is one of the most important variants in this family, especially in the lungs.

Roughly 40-50% of people (depending on ancestry) carry a null deletion in GSTM1, meaning they produce little to no GSTM1 enzyme. Without GSTM1, your lungs have significantly impaired ability to neutralize oxidative stress from smoke, pollution, and inflammation. Free radicals accumulate, damaging lung tissue and triggering more inflammation. Over time, this creates a vicious cycle: inflammation begets more oxidative stress, which begets more inflammation.

You notice this as worsening symptoms after exposure to smoke or pollution. Your cough gets worse, your breathlessness lingers longer, you feel the inflammation burning in your chest. Recovery takes days instead of hours. If you’re a smoker with GSTM1 null, your COPD risk is exponentially higher than someone with an intact GSTM1 gene.

Interleukin-13 (IL-13) is a master regulator of airway inflammation. When your immune system encounters an irritant, IL-13 tells your airway tissue to produce excess mucus, recruit eosinophils (a type of immune cell), and thicken the airway walls. In small doses, this is protective. But in people with IL-13 variants, the response is exaggerated.

Roughly 30-35% of people carry variants that increase IL-13 production. Higher IL-13 drives excessive airway eosinophilia, mucus hypersecretion, and progressive airway remodeling. Your airways don’t just inflame; they physically change shape, becoming thicker and narrower. This process is partly permanent.

You experience this as chronic mucus production, frequent productive coughs, and a sensation that your lungs are always congested. Your airways feel tight even when you’re not actively wheezing. Small exposures to irritants trigger prolonged inflammation. You might be labeled asthma-COPD overlap (ACO), but the root is genetic IL-13 hyperresponsiveness.

Vitamin D receptor (VDR) is the genetic switch that allows your cells to respond to vitamin D. Without functional VDR, even adequate vitamin D levels don’t translate into immune regulation. VDR variants affect how well your immune system can shift from inflammatory (Th1/Th17) to regulatory (Treg) responses, which is critical in the lungs.

Roughly 30-40% of people carry VDR variants that reduce its function (including FokI, BsmI, ApaI, and TaqI polymorphisms). With reduced VDR signaling, your immune system stays in a pro-inflammatory state, unable to dial down the immune response even after the threat is gone. Your lungs stay inflamed. Infections linger longer. Airway damage accelerates.

You notice this as infections that progress to bronchitis or pneumonia more easily than they should, prolonged coughing after any viral exposure, and baseline airway inflammation even when you’re not acutely ill. Your lungs never fully recover between illnesses. You feel like you’re always “getting over something.

Filaggrin (FLG) is a structural protein that builds the tight junctions in your skin and airway epithelium. Think of it as the mortar between bricks. When FLG is intact, allergens and irritants cannot penetrate the barrier. When FLG is defective, the barrier becomes porous.

Roughly 10% of people of European ancestry carry null mutations in FLG (R501X, 2282del4). FLG mutations create a leaky airway barrier, allowing smoke particles, allergens, and pathogens to directly contact immune cells in the tissue below. This triggers massive immune activation. Your lungs become hypersensitized to ever-smaller exposures.

You experience this as extreme sensitivity to smoke, perfumes, pollution, and cold air. Minimal exposures trigger coughing, bronchospasm, and inflammation. You might be told you have “reactive airways” or “chemical sensitivity.” The truth is your airway barrier is physically compromised. You’re not overreacting; your lungs are correctly reacting to an invasive trigger that shouldn’t reach the immune cells in the first place.

Tumor necrosis factor alpha (TNF-alpha) is one of the body’s most potent inflammatory signals. It’s released by immune cells in response to infection, irritation, or damage. In moderate amounts, it’s healing. In excess, it drives chronic inflammation, tissue damage, and airway remodeling.

Roughly 30% of people carry the TNF -308G>A variant (A allele), which increases TNF-alpha production. Higher TNF-alpha drives aggressive inflammation in the lungs, recruiting more immune cells, triggering more mucus production, and accelerating airway damage. Your inflammatory response is essentially stuck in the “on” position. Even after an initial trigger resolves, TNF levels stay elevated.

You notice this as persistent inflammation between exposures, slower recovery from infections, elevated inflammatory markers on bloodwork (CRP, ESR), and an overall feeling that your lungs are chronically angry. You might have been told you have “severe” COPD or asthma for what seems like a mild exposure history. Your genetics are driving the severity.